Sputnik V

Photo: ANI

Russia's Sputnik V Effective Against All Coronavirus Variants: Gamaleya's Ginsburg

According to Alexander Ginsburg, director of the Gamaleya National Research Center of Epidemiology and Microbiology in Russia, the Sputnik V vaccine shields all versions of Coronavirus, including the new kind of Delta strain. "The Sputnik V vaccine is effective against all variants," Ginsburg said, adding that "none of the variants has become more epidemically significant than the original variant." According to him, new Delta versions arise… read-more

Wed, 27 Oct 2021 - 03:02 PM / by Vidhi Jhunjhunwala

Tags: Sputnik-V, Russia, Coronavirus, Covid Vaccination

Sputnik light Russian vaccine

Photo: Odisha Tv

Sputnik Single-Dose Vaccine Trial Gets Approval From DGCI

The third Phase trial of the Sputnik light, a single-dose vaccine in India has been granted permission by the Drugs Controller General of India (DCGI). A study published in The Lancet showed Sputnik light has 78.6 to 83.7% efficacy against Covid. It is higher than two shot vaccines. The CDSCO committee stated that Sputnik light is the same as Sputnik V. Its safety or immunogenicity has been previously tested. 

Wed, 15 Sep 2021 - 03:27 PM / by Ettishree Shukla

Tags: covid 19, Sputnik-V, Russia, DCGI, Covid Vaccine

Courtesy: The Siasat Daily

Sputvik-5 vaccine

Photo: News 18

Sputnik-V: Interim Trials Show Promising Results

The Russian "Sputnik-V" vaccine has shown more than 90 percent effectiveness in the ongoing interim trials. According to a study by Lancet journal, Sputnik-V is effective against many variants of Covid-19. Hildegund C.J. Ertl, a vaccine scientist at Wistar Institute said that the "results are great". He also said that the Russian vaccine has proven to be one of the safest and effective vaccines in the world.

Tue, 13 Jul 2021 - 06:45 PM / by Umang Bafna

Tags: Sputnik-V, Russia, Covid-19 Vaccination, Russian Corona Vaccine

Courtesy: Washington Post


Photo: NDTV

DCGI Approves SII's Request To Manufacture Sputnik V In India

The Drug Controller General of India on June 4 approved the Serum Institute of India's request to manufacture Russian COVID-19 vaccine Sputnik-V. Adar Poonawalla-owned organisation has been granted permission to examine, test and analyse the vaccine in India. SII CEO Poonawalla thanked the Ministry of External Affairs and POTUS Joe Biden for relaxing the restrictions on vaccine manufacture. For the production, SII will join hands with… read-more

Sat, 05 Jun 2021 - 09:25 AM / by Nikita Thakur

Tags: SII, Adar Poonawalla, Sputnik-V, Russia, Covid-19, Covid Vaccine

Courtesy: Zee Business

Moscow, Russia.

Photo: TravelScapes

Travel Agency Offers 24-Day Russia Trip, Sputnik-V Jabs At Rs 1.29L

A Dubai-based travel agency has offered a 24-day trip from Delhi to Russia, where the tourists will be given two doses of Sputnik-V jab with certificate under the vaccine-tourism package. The whole trip costing Rs 1.29 lakh will also benefit the travellers with the sight-seeing around Moscow and St Petersburg. The package includes tickets, meals and 3-star hotel accommodation. However, interested travellers will have to pay Rs 10,000 as visa… read-more

Thu, 20 May 2021 - 12:56 PM / by Harsh Vardhan

Tags: Russia, Delhi, Moscow, Sputnik-V, St Peterburg, Vaccine Tourism

Courtesy: India .com

Delhi HC

Photo: The Sentinel Assam

Delhi HC Slams Centre, Asks To Prioritise Foreign Vaccine Procurement

In a plea that came up on May 18, the Delhi HC slammed the Centre for being negligent towards the collaboration and procurement of COVID-19 vaccines from foreign countries. Reportedly, the Centre is due to release funds for an Indian pharmaceutical company that collaborated with Russia's Sputnik vaccine manufacturers. HC said that the Central leaders are living in 'ivory towers' without knowing the ground reality of COVID-19 impact.

Wed, 19 May 2021 - 05:28 PM / by Vanshika Sharma

Tags: Covid Vaccination, Sputnik-V, Delhi HC, Centre

Courtesy: Times Of India

Sputnik V

Photo: Business Standard

Dr Reddy's Lab Rolls Russian Sputnik V In India At Rs 995 Per Dose

The Dr. Reddy's Laboratories on May 14 rolled out the Russian COVID-19 vaccine Sputnik V in India with the first dose administered in Hyderabad. The imported vaccine under current pilot project has been priced at Rs 995.4/dose including 5% GST. Expecting second and further imported consignments in upcoming months, DRL said supply from Indian manufacturers will commence soon. DRL also hoped of probably cheaper price when local supplies begin… read-more

Fri, 14 May 2021 - 05:54 PM / by Vanshika Sharma

Tags: Hyderabad, Russia, RDIF, Sputnik-V, Covid-19 Vaccination, Dr Reddy's

Courtesy: Times Of India

Sputnik V

Photo: USNews .com

Dr Reddy's Laboratories To Import Russia's COVID-19 Vaccine Sputnik V

Dr. Reddy's Laboratories is expected to receive 250 million doses of Russian vaccine ‘Sputnik V’ between April and June. Reportedly, the supply will be determined by considering the number of doses requested by the Centre and the cold chain mechanism in place to deliver them throughout the country. While, currently, Sputnik is negotiating with the government regarding the price, India will use the Russian Direct Investment Fund for its… read-more

Thu, 15 Apr 2021 - 11:38 AM / by Anvitha Shetty

Tags: Sputnik-V, Covid-19 Vaccine, India, Russia, RDIF

Sputnik V

Photo: Zee News

Indian Expert Committee Approves Sputnik V Vaccine For Emergency Use

The Indian subject expert committee on April 12, has approved the Russian Vaccine Sputnik V for the emergency use. This approval was made during the time of vaccine shortage in various states of the country. Partnered with Russian manufacturers, Dr. Reddy’s Laboratories will receive 100 million doses of the Sputnik V vaccine as agreed. Earlier, the expert committee sought information on Sputnik V vaccine clinical trials.

Mon, 12 Apr 2021 - 07:24 PM / by Neha Sanjeev

Tags: Russia, Covid Vaccine, Sputnik-V, Dr Reddy's

Courtesy: Deccan Herald

Covid Vaccine

Photo: DNA India

Dr Reddy's Seeks Emergency Use Approval Of Sputnik-V Vaccine

Pharmaceutical MNC Dr Reddy’s have applied for emergency use authorization of Russian COVID-19 vaccine ‘Sputnik-V’ in India. Showing 91.6% efficacy in the last-stage trials, the vaccine maker has assured to submit the test interim data by February 21. Produced by Moscow’s Gamaleya Institute and registered in almost 30 countries, the vaccine will be the most effective in India if approved. Reportedly, Reddy’s and Russian Development Investment… read-more

Fri, 19 Feb 2021 - 06:45 PM / by Nikita Thakur

Tags: Covid-19, Covid Vaccine, Dr Reddy's, Sputnik-V